Publications by authors named "Arshia Shizarpour"
Background: Early identification of gestational diabetes mellitus is essential for improving maternal and neonatal outcomes. While risk factors such as advanced maternal age, elevated pre-pregnancy body mass index, multiparity, and a history of gestational diabetes have been recognized, the role of serum biomarkers remains uncertain. This study explores the predictive value of early-pregnancy laboratory findings in conjunction with maternal demographic and clinical characteristics for gestational diabetes mellitus.
View Article and Find Full Text PDFPurpose: Distinguishing functional seizures (FS) from epileptic seizures (ES) poses a challenge due to similar clinical manifestations. The creation of a clinical scoring system that assists in accurately diagnosing patients with FS would be a valuable contribution to medical practice. This score has the potential to enhance clinical decision-making and facilitate prompt diagnosis of patients with FS.
View Article and Find Full Text PDFArticle Synopsis
- * The patient was hospitalized at 29 weeks due to elevated liver enzymes, later tested positive for COVID-19, leading to complications like placental insufficiency affecting two of the three fetuses.
- * Following a cesarean section, one baby survived while the other two unfortunately died shortly after birth; the mother recovered and was discharged in good condition three days later.
Article Synopsis
- A cohort study was conducted comparing pregnant women with COVID-19 to those without, including 199 participants admitted to Arash Hospital in Tehran from March to September 2020.
- The study found that COVID-19 infected pregnant women had a higher likelihood of cesarean section deliveries compared to non-infected women, but no significant differences in other maternal and fetal outcomes like preterm birth or low birth weight were observed.
- Notably, a significant number of COVID-19 infected patients required ICU admission, highlighting potential risks in their recovery compared to the non-infected group.
Objectives: Comparison of the effect of hydroxychloroquine with placebo to prevent infection from the COVID -19 virus among healthcare professionals TRIAL DESIGN: Single centre, 2-arm, double-blind randomised (ratio 1:1) placebo-controlled trial PARTICIPANTS: Treatment staff who are in contact with patients and have at least 3 shifts a week in Arash hospital affiliated with Tehran University of Medical Sciences, in Iran and who consent to participate in the study. Exclusion criteria include: History of COVID -19 virus infection, clinical symptoms such as fever, nausea, dyspnea and myalgia in the past two months, history of underlying diseases hypersensitivity to hydroxychloroquine and G6PD enzyme deficiency.
Intervention And Comparator: Intervention group: Hydroxychloroquine 200 mg tablet of Amin Pharmaceutical.